Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00430690 · ClinicalTrials.gov registry record

Acoustic Startle Reduction In Cocaine Dependence

A clinical trial, sponsored by Emory University.

Completed
Registry status
144
Enrollment target

NCT00430690 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 144 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00430690 has completed, sponsored by Emory University.

COMPLETED
Registry status
144 participants
Enrollment target

Study Summary

Chronic cocaine administration leads to changes in brain function that persist long after the acute withdrawal phase. The acoustic startle response (ASR) is a well characterized reflexive response to a sudden acoustic stimulus. The ASR is mediated by a simple 3-synapse subcortical circuit; it is modulated in part by brain areas and neurotransmitters associated with cocaine administration. Our initial study and subsequent replication reveals a profound diminution of the ASR in cocaine-dependent subjects after a brief period of abstinence. Our preliminary findings indicate that first degree relatives of cocaine-dependent subjects also have reduced startle compared to healthy controls. The findings of low ASR in rats and humans during cocaine washout and low ASR in family members suggests there may be both a trait and state component of the startle reductions we have reported. The central objectives of this proposal are to dissect this finding with regard to its development and persistence in early and later phases of cocaine abstinence in humans; to ascertain whether startle reduction and its potential normalization during later abstinence is a predictor of clinical course in human subjects with cocaine dependence; and to examine whether startle reduction is, at least in part, a vulnerability trait for the development of cocaine dependence. This latter Aim will be carried out in humans by testing siblings of cocaine-dependent subjects. Cocaine dependence is an enormous public health problem. The significance of this work lies in the potential for the ASR reduction to serve as a reliable, easily repeatable biological measure of cocaine-induced brain changes that may enhance outcome prediction so that tailored treatments may be directed at those patients most vulnerable to relapse, given the restriction of resources for available for substance abuse treatment.

Interventions

  • PROCEDURE acoustic startle testing

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2006-09
Est. Completion 2011-07-19

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00430690

The ClinicalTrials.gov registry entry for NCT00430690 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which acoustic startle testing is the first listed.

NCT00430690 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00430690 about?

NCT00430690 is a clinical study titled "Acoustic Startle Reduction In Cocaine Dependence". Chronic cocaine administration leads to changes in brain function that persist long after the acute withdrawal phase. The acoustic startle response (ASR) is a well characterized reflexive response to a sudden acoustic stimulus. The ASR is mediated by a simple 3-synapse subcortical circuit; it is mod...

What is the current status of trial NCT00430690?

This trial is currently completed. The enrollment target is 144 participants. The study started on 2006-09. Estimated completion is 2011-07-19.

What interventions are being tested in trial NCT00430690?

The interventions under investigation include: acoustic startle testing (PROCEDURE).

Who is sponsoring clinical trial NCT00430690?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.